Flacking for Wal-Mart

  • by: |
  • 09/21/2006

There has been a lot of mis-reporting about which think tanks take what position on Wal-Mart policies…Here is one position we support..Wal-Mart’s program to make generic drugs even cheaper for millions of Americans and for most of its associates. As for Wal-Mart itself, can’t beat the prices on most items and now that goes for a lot of medicines. The Wal-Mart press release is below:

BENTONVILLE, Ark. â Sept. 21, 2006 â As part of its ongoing commitment to providing more affordable healthcare for Americaâs working families, Wal-Mart Stores, Inc. (NYSE: WMT) today announced that it will make nearly 300 generic drugs available for only $4 per prescription for up to a 30-day supply at commonly prescribed dosages. The program, to be launched on Friday, will be available to customers and associates of the 65 Wal-Mart, Neighborhood Market and Samâs Club pharmacies in Tampa Bay , Fla. area, and will be expanded to the entire state in January 2007.

âEach day in our pharmacies we see customers struggle with the cost of prescription drugs,â said Wal-Mart CEO H. Lee Scott, Jr. âBy cutting the cost of many generics to $4, we are helping to ensure that our customers and associates get the medicines they need at a price they can afford. Thatâs a real solution for our nationâs working families.â

Key components of the program include:

* The $4 pricing will be available to all pharmacy customers with a prescription from a doctor that can be filled with a covered generic medicine.

* This program will be available to the uninsured.

* Insurance will be accepted.

* The program presently covers 291 generic medications from many of the most common therapeutic categories.

* The medicines represented are used to treat and manage conditions including allergies, cholesterol, high blood pressure and diabetes. Some antibiotics, antidepressants, antipsychotics and prescription vitamins are also included.

* The program will be available statewide in Florida in January 2007.

* Wal-Mart intends to take the program to as many states as possible next year.

âCompetition and market forces have been absent from our healthcare system, and that has hurt working families tremendously,â Scott said. âWe are excited to take the lead in doing what we do best â driving costs out of the system â and passing those savings to our customers and associates.â

The program will help alleviate a major challenge for seniors who have fallen into the âdoughnut holeâ coverage gap in their Medicare Part D prescription drug plans and now find themselves responsible for paying 100 percent of their prescription medicine costs.

âThis act of good corporate citizenship will help consumers manage healthcare costs, while benefiting Florida âs growing population,â said Florida Governor Jeb Bush. âIn addition to providing a great service, Wal-Mart is encouraging important conversations between patients and their doctors about the cost savings associated with generic prescriptions. I am pleased Wal-Mart chose Florida to launch this initiative where our large population of seniors will greatly benefit.â

âFifty-bucks for a yearâs supply of prescription drugs is a pretty darn good deal for consumers,â said U.S. Senator Bill Nelson (D-FL), an outspoken proponent of giving people access to lower-cost prescriptions. âBecause Wal-Mart has the ability to shape the market, maybe other retailers will follow suit.â

In addition, the program provides a solution for the nearly 2.7 million uninsured Floridians who may also avoid filling prescriptions and remain untreated. Wal-Mart estimates that the program will save the stateâs Medicaid program hundreds of thousands of dollars annually.

In announcing the program, Bill Simon, executive vice president of the Professional Services Division for Wal-Mart, noted that purchasing a 30-day supply of the popular diabetes drug, Metformin, for $4 represents a nearly 50 percent savings from the cost of the brand name version of the drug. In addition, purchasing a 30-day supply of the brand name blood-pressure drug typically costs $12. Getting the generic, Lisinopril, for $4 saves customers nearly $100 annually.

âThese are medicines for diabetes, cardiovascular disease, asthma, colds and infections â the kinds of medicines that working families need so they can treat illness, manage conditions and stay well,â said Simon. âRising healthcare costs are eating up more and more of familiesâ budgets, so this program brings a lot of value to our customers, associates and communities.â

Generic medications contain the same active ingredients as their âbrand-nameâ counterparts and are equally effective, but cost significantly less. Consumers interested in saving money on prescriptions through the program should ask their doctor if a generic is available for their prescription and is right for them. At this time, the $4 prescriptions are not available by mail order and are available on-line only for in-person pickup in the Tampa Bay, Fla. area. Not all generics in each therapeutic category are included.


Center for Medicine in the Public Interest is a nonprofit, non-partisan organization promoting innovative solutions that advance medical progress, reduce health disparities, extend life and make health care more affordable, preventive and patient-centered. CMPI also provides the public, policymakers and the media a reliable source of independent scientific analysis on issues ranging from personalized medicine, food and drug safety, health care reform and comparative effectiveness.

Blog Roll

Alliance for Patient Access Alternative Health Practice
Better Health
Biotech Blog
CA Medicine man
Cafe Pharma
Campaign for Modern Medicines
Carlat Psychiatry Blog
Clinical Psychology and Psychiatry: A Closer Look
Conservative's Forum
Club For Growth
Diabetes Mine
Disruptive Women
Doctors For Patient Care
Dr. Gov
Drug Channels
DTC Perspectives
Envisioning 2.0
FDA Law Blog
Fierce Pharma
Fresh Air Fund
Furious Seasons
Gel Health News
Hands Off My Health
Health Business Blog
Health Care BS
Health Care for All
Healthy Skepticism
Hooked: Ethics, Medicine, and Pharma
Hugh Hewitt
In the Pipeline
In Vivo
Internet Drug News
Jaz'd Healthcare
Jaz'd Pharmaceutical Industry
Jim Edwards' NRx
Kaus Files
Laffer Health Care Report
Little Green Footballs
Med Buzz
Media Research Center
More than Medicine
National Review
Neuroethics & Law
Nurses For Reform
Nurses For Reform Blog
Opinion Journal
Orange Book
Peter Rost
Pharm Aid
Pharma Blog Review
Pharma Blogsphere
Pharma Marketing Blog
Pharmacology Corner
Pharmaceutical Business Review
Piper Report
Prescription for a Cure
Public Plan Facts
Real Clear Politics
Shark Report
Shearlings Got Plowed
Taking Back America
Terra Sigillata
The Cycle
The Catalyst
The Lonely Conservative
Town Hall
Washington Monthly
World of DTC Marketing
WSJ Health Blog